Search clinical trials for: EMPAGLIFLOZIN PLACEBO
Total 54011 results
-
University of Sao Paulo General HospitalRecruitingCoronary Artery Disease | Diabetes Mellitus, Type 2 | Acute Kidney InjuryBrazil
-
Yonsei UniversityUnknownType2 Diabetes | NAFLD - Nonalcoholic Fatty Liver DiseaseKorea, Republic of
-
Zhongshan Hospital Xiamen UniversityUnknownDiabetic Nephropathy | Type 2 DiabetesChina
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus, Type 2 | Diabetic Kidney DiseaseNetherlands
-
University of California, San DiegoJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsCompleted
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 DiabetesTaiwan, United States, Argentina, Canada, Mexico, Puerto Rico, Philippines, India, Peru
-
YangjinPeking University Third HospitalNot yet recruitingPrediabetic State | Impaired Glucose Tolerance | Impaired Fasting GlucoseChina
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
McGill University Health Centre/Research Institute...RecruitingChronic Kidney Diseases | Acute Heart FailureCanada
-
Jinnah Postgraduate Medical CentreNot yet recruitingNon-Alcoholic Fatty Liver Disease | Type2diabetesPakistan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
University at BuffaloCompletedType 1 Diabetes MellitusUnited States
-
AstraZenecaCompleted
-
AstraZenecaContract Research Organization: USA; PAREXEL Early Phase Clinical Unit Baltimore and other collaboratorsCompletedAsymptomatic HyperuricemiaUnited States
-
University Hospital, RouenAstraZenecaNot yet recruitingRenal Insufficiency, ChronicFrance
-
Oregon State UniversitySamaritan Health ServicesRecruitingPreDiabetes | Prediabetic State | Overweight and ObesityUnited States
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
Duke UniversityRecruitingDiabetes Mellitus, Type 2 | Kidney Transplant; ComplicationsUnited States
-
Caroline M KistorpRigshospitalet, Denmark; Herlev and Gentofte Hospital; Danish Heart FoundationCompletedType2 Diabetes MellitusDenmark
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Australia, Greece, Italy, Norway, Poland, Portugal, Sweden
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingSTEMI | Left Ventricular Dysfunction | NSTEMI | AMIFrance
-
Maastricht University Medical CenterRecruitingHeart Failure With Preserved Ejection Fraction | Microvascular DysfunctionNetherlands
-
Matthieu Pelletier-Galarneau, MD MScNot yet recruiting
-
Research Institute for Complex Problems of Cardiovascular...CompletedCoronary Artery Disease | Diabetes Mellitus | Percutaneous Coronary Intervention
-
National University of MalaysiaUnknownDiabetes Mellitus | Chronic Kidney Diseases | Diabetic RetinopathyMalaysia
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedSubstance-Related Disorders | Depression | HIV InfectionsUnited States
-
AstraZenecaCompletedBioequivalence | Fixed Dose Combination Tablets | Healthy Male and Female SubjectsUnited States
-
Tanta UniversityNot yet recruitingNon Alcoholic SteatohepatitisEgypt
-
University Hospital TuebingenActive, not recruiting
-
Unity Health TorontoBoehringer Ingelheim; Canadian Medical and Surgical Knowledge Translation Research... and other collaboratorsCompletedCardiovascular Diseases | Left Ventricular HypertrophyCanada, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
University at BuffaloCompletedType 1 DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Jichi Medical UniversityEli Lilly and Company; Boehringer IngelheimCompletedT2DM (Type 2 Diabetes Mellitus) | Nocturnal HypertensionJapan
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Weill Medical College of Cornell UniversityWithdrawnDiabetes Mellitus, Type 2United States
-
University of Alabama at BirminghamNot yet recruitingObesity | Weight LossUnited States
-
Postgraduate Institute of Medical Education and...RecruitingCirrhosis | Ascites HepaticIndia
-
The George InstituteVictor Chang Cardiac Research Institute; St Vincent's Centre for Applied Medical...RecruitingHeart Failure With Preserved Ejection FractionAustralia
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownType 2 Diabetes Mellitus
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAcute Kidney Injury | Cardiac Surgery | Sodium-Glucose Transporter 2 InhibitorNetherlands
-
AstraZenecaRecruiting
-
Ain Shams UniversityDrug Research Centre, Cairo, EgyptCompletedDiabetes Mellitus | Pharmacokinetics | PharmacodynamicsEgypt